Neuropsychological deficits and Alzheimer’s disease biomarkers in subjective cognitive decline

Takeaway

  • Poor performance of people with subjective cognitive decline (SCD) in testing of five cognitive domains was moderately associated with biomarkers of Alzheimer’s disease (AD) pathology.

Why this matters

    The current study is the first to evaluate the association between subtle neurophysiological deficits and cerebrospinal fluid (CSF) biomarkers in a large population of people with SCD compared with healthy controls.